CAS No.
[16679-58-6 (Unlabeled) (Free base)]
Therapeutic Uses
Synthetic Peptides
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
2,2,2-trifluoroacetic acid compound with (Z)-1-((5Z,8Z,11Z,14Z,17Z)-13-benzyl-2,3,4,5,6-d5-6,9,12,15,18-pentahydroxy-7-(2-hydroxy-2-iminoethyl)-10-(3-hydroxy-3-iminopropyl)-16-(4-hydroxybenzyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl)-N-((Z)-5-guanidino-1-hydroxy-1-((2-hydroxy-2-iminoethyl)imino)pentan-2-yl)pyrrolidine-2-carbimidic acid (1:1)
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
No -Refer MSDS for accurate information
Desmopressin-d5 TFA is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Desmopressin-d5 TFA usage and description
Desmopressin-D5 TFA is a synthetic analog of vasopressin, a hormone produced in the hypothalamus and released by the pituitary gland. It is used primarily for the treatment of central diabetes insipidus, a condition characterized by the production of large amounts of dilute urine due to a lack of antidiuretic hormone (ADH). Desmopressin-D5 TFA works by increasing the levels of ADH in the body, which reduces the amount of urine produced and increases the concentration of urine.
Desmopressin-D5 TFA is administered intranasally, subcutaneously, or intravenously, depending on the severity of the condition being treated. The dosage and administration method will vary depending on the patient's age, weight, and medical history.
Chemically, Desmopressin-D5 TFA is a deuterated analog of desmopressin acetate, a synthetic version of vasopressin. The deuterium atoms present in Desmopressin-D5 TFA act as a tracer, allowing for the determination of the pharmacokinetic properties of the drug. The TFA (trifluoroacetic acid) salt form of the drug is used to increase its stability and solubility.
Desmopressin-D5 TFA is generally well-tolerated by patients, with few side effects reported. However, it should be used with caution in patients with a history of hyponatremia or heart failure, as it can lead to fluid retention and electrolyte imbalances. Overall, Desmopressin-D5 TFA is an effective and safe treatment option for patients with central diabetes insipidus.
